参考文献
(在框内滑动手指即可浏览)
[1] Wang L,Zhou B,Zhao Z,et al.Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18[J].Lancet,2021,398(10294):53-63.
[2] Zhang X,Zhang M,Zhao Z,et al.Geographic variation in prevalence of adult obesity in China: Results from the 2013-2014 national chronic disease and risk factor surveillance[J].Ann Intern Med,2020,172(4):291-293.
[3] 郑成竹,柯重伟,印慨,等.腹腔镜垂直捆绑胃成形术治疗病态肥胖(附25例报告)[J].中国实用外科杂志,2002,22(10):591-593.
[4] 杨华,陈缘,董志勇,等.中国肥胖代谢外科数据库:2020 年度报告 [J].中华肥胖与代谢病电子杂志,2021,7(1):1-7.
[5] Melinek J,Livingston E,Cortina G,et al.Autopsy findings following gastric bypass surgery for morbid obesity[J].Arch Pathol Lab Med,2002,126(9):1091-1095.
[6] 上海市普通外科临床质量控制中心.上海市普通外科病人静脉血栓栓塞症防治管理规范(2020版)[J].中国实用外科杂志,2020,40(5):481-487.
[7] 上海市普通外科临床质量控制中心.上海市普通外科住院病人静脉血栓栓塞症防治管理规范[J].中国实用外科杂志,2018,38(3):245-249.
[8] 张鹏,赵莹,田沛荣,等.京津冀晋地区减重与代谢外科围手术期静脉血栓栓塞症防治现状调查分析[J].中国实用外科杂志,2021,41(3):320-325.
[9] Beckman MG,Hooper WC,Critchley SE,et al.Venous thromboembolism: a public health concern[J].Am J Prev Med,2010,38(suppl 4):495-501.
[10] Heit JA,Spencer FA, White RH. The epidemiology of venous thromboembolism [J]. J Thromb Thrombolysis,2016,41(1):3-14.
[11] Ageno W,Becattini C,Brighton T,et al.Cardiovascular risk factors and venous thromboembolism: a meta-analysis[J].Circulation,2008,117(1):93-102.
[12] Fontaine GV,Vigil E,Wohlt PD,et al.Venous thromboembolism in critically ill medical patients receiving chemoprophylaxis: A focus on obesity and other risk factors[J].Clin Appl Thromb Hemost,2016,22(3):265-273.
[13] Eichinger S,Hron G,Bialonczyk C,et al.Overweight, obesity, and the risk of recurrent venous thromboembolism[J].Arch Intern Med,2008,168(15):1678-1683.
[14] Horvei LD,Brækkan SK,Hansen JB.Weight change and risk of venous thromboembolism: The tromsø study[J].PLoS One,2016,11(12):e0168878.
[15] Wendelboe AM,McCumber M,Hylek EM,et al.Global public awareness of venous thromboembolism[J].J Thromb Haemost,2015,13(8):1365-1371.
[16] Liew NC,Alemany GV,Angchaisuksiri P,et al.Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism[J].Int Angiol,2017,36(1):1-20.
[17] Yhim HY,Jang MJ,Bang SM,et al.Incidence of venous thromboembolism following major surgery in Korea: from the health insurance review and assessment service database[J].J Thromb Haemost,2014,12(7):1035-1043.
[18] Wu PK,Chen CF,Chung LH,et al.Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis[J].Thromb Res,2014,133(5):719-724.
[19] 楼文晖,程健,李聚欣,等.上海市普通外科住院病人静脉血栓栓塞症诊治现状调查分析[J].中国实用外科杂志,2020,40(5):542-546.
[20] Nelson RE,Grosse SD,Waitzman NJ,et al.Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in department of veterans affairs hospitals, 2005-2010[J].Thromb Res,2015,135(4):636-642.
[21] 朱萍芳,黄晓娜,庄欢,等.腹腔镜袖状胃切除术围手术期静脉血栓栓塞的预防策略[J].腹腔镜外科杂志,2018,23(1):26-30.
[22] Bhatia P,John SJ,Kalhan S,et al.Portomesenteric venous thrombosis after laparoscopic sleeve gastrectomy: A case report and a call for prevention[J].J Minim Access Surg,2015,11(4):276-278.
[23] Winegar DA,Sherif B,Pate V,et al.Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the bariatric outcomes longitudinal database[J].Surg Obes Relat Dis,2011,7(2):181-188.
[24] Froehling DA,Daniels PR,Mauck KF,et al.Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study[J].Obes Surg,2013,23(11):1874-1879.
[25] Steele KE,Schweitzer MA,Prokopowicz G,et al.The long-term risk of venous thromboembolism following bariatric surgery[J].Obes Surg,2011,21(9):1371-1376.
[26] 朱信强,单晓东,马济雷,等.两种代谢手术治疗肥胖型2型糖尿病的对比分析[J].中华普外科手术学杂志(电子版),2020,14(5):476-479.
[27] Bariatric LA,Flum DR,Belle SH,et al.Perioperative safety in the longitudinal assessment of bariatric surgery[J].N Engl J Med,2009,361(5):445-454.
[28] for Metabolic AS.ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients[J].Surg Obes Relat Dis,2013,9(4):493-497.
[29] Aminian A,Vosburg RW,Altieri MS,et al.The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery[J].Surg Obes Relat Dis,2021 Nov 10;S1550-7289(21)00521-9. doi: 10.1016/j.soard.2021.10.023.
Online ahead of print.
[30] Finks JF,English WJ,Carlin AM,et al.Predicting risk for venous thromboembolism with bariatric surgery: results from the michigan bariatric surgery collaborative[J].Ann Surg,2012,255(6):1100-1104.
[31] Dang JT,Switzer N,Delisle M,et al.Predicting venous thromboembolism following laparoscopic bariatric surgery: development of the BariClot tool using the MBSAQIP database[J].Surg Endosc,2019,33(3):821-831.
[32] Aminian A,Andalib A,Khorgami Z,et al.Who should get extended thromboprophylaxis after bariatric surgery?: A risk assessment tool to guide indications for post-discharge pharmacoprophylaxis[J].Ann Surg,2017,265(1):143-150.
[33] Thavarajah D,Wetherill M.Implementing NICE guidelines on risk assessment for venous thromboembolism: failure, success and controversy[J].Int J Health Care Qual Assur,2012,25(7):618-624.
[34] Nicholson M,Chan N,Bhagirath V,et al.Prevention of venous thromboembolism in 2020 and beyond[J].J Clin Med,2020,9(8):2467.
[35] 张频.减重手术围手术期静脉血栓栓塞症防治[J].中国实用外科杂志,2020,40(4):387-389.
[36] Weitz JI,Fredenburgh JC,Eikelboom JW.A test in context: D-dimer[J].J Am Coll Cardiol,2017,70(19):2411-2420.
[37] Duranteau J,Taccone FS,Verhamme P,et al.European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care[J].Eur J Anaesthesiol,2018,35(2):142-146.
[38] Froylich D,Corcelles R,Davis M,et al.Factors associated with length of stay in intensive care after bariatric surgery[J].Surg Obes Relat Dis,2016,12(7):1391-1396.
[39] Morgan DJR,Ho KM,Armstrong J,et al.Incidence and risk factors for intensive care unit admission after bariatric surgery: a multicentre population-based cohort study[J].Br J Anaesth,2015,115(6):873-882.
[40] Frantzides CT,Welle SN,Ruff TM,et al.Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass[J].JSLS,2012,16(1):33-37.
[41] Clements RH,Yellumahanthi K,Ballem N,et al.Pharmacologic prophylaxis against venous thromboembolic complications is not mandatory for all laparoscopic Roux-en-Y gastric bypass procedures[J].J Am Coll Surg,2009,208(5):917-913.
[42] Abuoglu HH,Müftüoglu MAT,Odabaşı M.A new protocol for venous thromboembolism prophylaxis in bariatric surgery[J].Obes Surg,2019,29(2):729-734.
[43] Venclauskas L,Maleckas A,Arcelus JI,et al.European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the obese patient[J].Eur J Anaesthesiol,2018,35(2):147-153.
[44] Steele KE,Canner J,Prokopowicz G,et al.The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial[J].Surg Obes Relat Dis,2015,11(3):672-683.
[45] Gould MK,Garcia DA,Wren SM,et al.Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141(suppl 2):e227.
[46] Ahmad KS,Zayed ME,Faheem MH,et al.Incidence of silent deep venous thrombosis after laparoscopic bariatric surgery in patients who received combined mechanical and chemical thromboprophylaxis compared to patients who received mechanical thromboprophylaxis only[J].Surg Innov,2021,28(1):144-150.
[47] Altieri MS,Yang J,Hajagos J,et al.Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures[J].Surg Endosc,2018,32(12):4805-4812.
[48] Okonek MJB,Hart RW,Pantano JE,et al.Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity[J].Surg Obes Relat Dis,2008,4(5):625-631.
[49] Hamadi R,Marlow CF,Nassereddine S,et al.Bariatric venous thromboembolism prophylaxis: an update on the literature[J].Expert Rev Hematol,2019,12(9):763-771.
[50] Kröll D,Stirnimann G,Vogt A,et al.Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery[J].Br J Clin Pharmacol,2017,83(7):1466-1475.
[51] Birkmeyer NJO,Share D,Baser O,et al.Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery[J].Ann Surg,2010,252(2):313-318.
[52] Birkmeyer NJ,Finks JF,English WJ,et al.Risks and benefits of prophylactic inferior vena cava filters in patients undergoing bariatric surgery[J].J Hosp Med,2013,8(4):173-177.
[53] Raftopoulos I,Martindale C,Cronin A,et al.The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial[J].Surg Endosc,2008,22(11):2384-2391.
[54] Brunetti L,Wassef A,Sadek R,et al.Anticoagulant activity of enoxaparin and unfractionated heparin for venous thromboembolism prophylaxis in obese patients undergoing sleeve gastrectomy[J].Surg Obes Relat Dis,2019,15(3):363-373.
[55] Birkmeyer NJO,Finks JF,Carlin AM,et al.Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery[J].Arch Surg,2012,147(11):994-998.
[56] Schijns W,Deenen MJ,Aarts EO,et al.The effect of obesity on anti-xa concentrations in bariatric patients[J].Obes Surg,2018,28(7):1997-2005.